英国HIV感染男男性行为者HCV发病率下降:迈向微消除?
这项在伦敦和布莱顿5家HIV门诊开展的回顾性队列研究,分析了2013-2018年HIV感染MSM的急性HCV感染趋势。急性HCV发病率在2015年达峰值14.57/1000人年,至2018年降至4.63/1000人年;诊断至治疗时间从2013年29.8个月缩短至2018年3.7个月。自2015年峰值以来,首次HCV感染发病率下降78%,总体HCV发病率下降68%,与英格兰DAA可及性扩大相吻合。
要点
- HIV感染MSM急性HCV发病率2015年达峰后显著下降。
- 诊断至DAA治疗启动时间从29.8个月缩短至3.7个月。
- 自2015年峰值以来总体HCV发病率下降68%。
核心结论
- 自2015年疫情峰值以来,HIV感染MSM中首次HCV发作发病率下降78%,总体HCV发病率下降68%。
- 发病率下降与英格兰DAA可及性扩大在时间上相吻合。
- 要实现该人群HCV微消除,可能仍需更早治疗和再感染干预等进一步措施。
研究设计与样本
- 2013至2018年在伦敦和布莱顿5家HIV门诊开展的回顾性队列研究。
- 各中心报告研究期间所有急性HCV发作,并收集治疗时机数据。
- 共识别378例急性HCV感染,包括292例首次感染和86例再感染。
主要发现
- 急性HCV发病率在2015年达峰值14.57/1000人年(95%CI 10.95-18.20)。
- 2018年发病率降至4.63/1000人年(95%CI 2.60-6.67)。
- 诊断至开始治疗时间从2013年29.8个月降至2018年3.7个月。
临床怎么用
- HIV感染MSM应扩大DAA治疗可及性,以降低HCV发病率。
- 需关注再感染,并考虑更早治疗等进一步干预以实现微消除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Modeling of the London hepatitis C virus (HCV) epidemic in men who have sex with men (MSM) and are living with human immunodeficiency virus (HIV) suggested that early access to direct-acting antiviral (DAA) treatment may reduce incidence. With high rates of linkage to care, microelimination of HCV within MSM living with HIV may be realistic ahead of 2030 World Health Organization targets. We examined trends in HCV incidence in the pre- and post-DAA eras for MSM living with HIV in London and Brighton, United Kingdom. METHODS: A retrospective cohort study was conducted at 5 HIV clinics in London and Brighton between 2013 and 2018. Each site reported all acute HCV episodes during the study period. Treatment timing data were collected. Incidence rates and reinfection proportion were calculated. RESULTS: A total of. UNLABELLED: 378 acute HCV infections were identified, comprising 292 first infections and 86 reinfections. Incidence rates of acute HCV in MSM living with HIV peaked at 14.57/1000 person-years of follow-up (PYFU; 95% confidence interval [CI], 10.95-18.20) in 2015. Rates fell to 4.63/1000 PYFU (95% CI, 2.60 to 6.67) by 2018. Time from diagnosis to starting treatment declined from 29.8 (2013) to 3.7 months (2018). CONCLUSIONS: We observed a 78% reduction in the incidence of first HCV episode and a 68% reduction in overall HCV incidence since the epidemic peak in 2015, which coincides with wider access to DAAs in England. Further interventions to reduce transmission, including earlier access to treatment and for reinfection, are likely needed for microelimination to be achieved in this population.
引用
- Garvey LJ, Cooke GS, Smith C, et al. Decline in Hepatitis C Virus (HCV) Incidence in Men Who Have Sex With Men Living With Human Immunodeficiency Virus: Progress to HCV Microelimination in the United Kingdom? Clin Infect Dis. 2021. PMID: 32211763. doi:10.1093/cid/ciaa021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。